Suresh S Ramalingam
researcher
2 stories
1 quote
The fact that it shows an improvement in overall survival in a difficult-to-treat patient population is very encouraging,
- said Dr. Suresh Ramalingam, executive director of the Winship Cancer Institute of Emory UniversityCNBCcnbc.com/2026/05…
Earlier
Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
South China Morning Postscmp.com/business/china…Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung cancer
The Independentindependent.co.uk/news/health…After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
NBC Newsnbcnews.com/health/health…For decades, scientists have worked relentlessly trying to find clever solutions for a form of cancer that is often found late
Guardiantheguardian.com/society/2026…